Showing results (4161-4170 of 6,795) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|November 19, 2008
Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: a Phase I, open-label, dose-escalation clinical studyDaniel J Burge, Stephen A Bookbinder, Alan J Kivitz, et al.
Clinical Therapeutics|November 19, 2008
Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I studyKyoung Soo Lim, Jung-Ryul Kim, Yun-Jung Choi, et al.
Clinical Therapeutics|November 19, 2008
Bioequivalence of generic lamotrigine 100-mg tablets in healthy Thai male volunteers: a randomized, single-dose, two-period, two-sequence crossover studyArunee Srichaiya, Chaowanee Longchoopol, Sarawut Oo-Puthinan, et al.
Clinical Therapeutics|September 11, 2007
Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumorsVal R Adams, Markos Leggas
Clinical Therapeutics|September 11, 2007
Absolute bioavailability of intranasal fluticasone furoate in healthy subjectsAnn Allen, Geoff Down, Amy Newland, et al.
Clinical Therapeutics|August 13, 2020
Assessment of the Regulatory Dialogue Between Pharmaceutical Companies and the European Medicines Agency on the Choice of Noninferiority MarginsTurki A Althunian, Anthonius de Boer, Aukje K Mantel-Teeuwisse, et al.
Clinical Therapeutics|August 13, 2020
Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences-Ibero-American Network of Pharmacogenetics and Pharmacogenomics MeetingEva Peñas-LLedó, Enrique Terán, Marta Sosa-Macías, et al.
Clinical Therapeutics|March 10, 2015
Cytotoxic T-lymphocyte antigen-4 blockade in melanomaElizabeth I Buchbinder, David F McDermott
Clinical Therapeutics|March 10, 2015
Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched usersFrançois Laliberté, Michel Cloutier, Concetta Crivera, et al.
Clinical Therapeutics|August 26, 2020
Comparison of the Pharmacokinetic and Pharmacodynamic Relationship of Ipragliflozin Between Patients With Type 1 and Type 2 Diabetes MellitusJunko Toyoshima, Masako Saito, Atsunori Kaibara, et al.
Pageof 680